Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide in Ischaemic Heart Disease (LIONESS)
NCT02315001Phase 2Completed
- Sponsor
- King's College London
- Start
- Jan 2014
- Primary completion
- Mar 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of liraglutide in ischaemic heart disease (IHD), sponsored by King's College London. Started Jan 2014; status: completed.
02
Drugs
03
Conditions
ischaemic heart disease (IHD)
Beyond the preview
Go deeper on NCT02315001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02315001.